Posts in: press clippings

Webull 'Biotech Sector' webinar by Perriman
investorpress clippingsvideopodcastperriman
Webull: 'Biotech Sector' webinar by Damien PerrimanJune 30, 2026
Biomass Magazine
biofuelmedicinepress clippingsscience
Biomass Magazine: Why Use Living Cells? NLR Is Making Chemicals With Enzymes AloneJune 29, 2026
Bionity.com
press clippingscannabinoids
Bionity.com: EXOZ awarded $2M NIH grant to advance cannabinoid analogues for drug discoveryJune 26, 2026
PRISM MarketView
press clippingscannabinoids
PRISM MarketView: NIH Cash Fuels eXoZymes’ Push Into Next‑Gen CannabinoidsJune 25, 2026
Ladder17 podcast: How eXoZymes is Scaling as a Public Company
nutraceuticalspress clippingspodcastperrimanNCT
Ladder17 podcast: How eXoZymes is Scaling as a Public CompanyJune 25, 2026
Rolling Stone: Next-gen cannabinoids - the innovative race to manufacture compounds
investormedicinepress clippingscannabinoids
Rolling Stone: Next-gen cannabinoids - the innovative race to manufacture compoundsMay 15, 2026
Finding Genius: eXoZymes AI-Enhanced Enzymes & The Future Of Sustainable Manufacturing
press clippingssciencepodcastNCTcannabinoidskorman
Finding Genius podcast: AI enhanced enzymes & the future of sustainable manufacturingMay 12, 2026
WTR Healthcare Happenings
heltzennutraceuticalspress clippingspodcastNCT
WTR podcast: Unlocking Hard-to-Scale Molecules with AI-Driven, Cell-Free BiomanufacturingMay 6, 2026
Podcast: CEO Heltzen @ Executive Insights for Life Sciences Innovators
heltzenpress clippingsvideopodcast
Podcast: CEO Heltzen @ Executive Insights for Life Sciences InnovatorsApril 20, 2026
Damien Perriman interviewed for Springwise
press clippingsperrimanNCT
Springwise case study: Unpacking how eXoZymes and Cayman Chemical are rethinking chemical manufacturingApril 17, 2026
Previous page
Page 1 of 5
Next page